Reliable Biopharmaceutical
Reliable Biopharmaceutical, headquartered in the United States, is a prominent player in the biopharmaceutical industry, specialising in the development and manufacturing of high-quality biologics and pharmaceuticals. Founded in 2004, the company has established itself as a trusted partner in the healthcare sector, with significant operations across North America and Europe. The firm is renowned for its innovative approach to biopharmaceutical production, offering a range of services including contract manufacturing, analytical testing, and regulatory support. Reliable Biopharmaceutical's commitment to quality and compliance has earned it a strong market position, with notable achievements in meeting stringent regulatory standards. By focusing on customer-centric solutions, the company continues to lead in the biopharmaceutical landscape, ensuring the delivery of safe and effective therapies.
DitchCarbon Score
How does Reliable Biopharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Reliable Biopharmaceutical's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Reliable Biopharmaceutical's reported carbon emissions
Reliable Biopharmaceutical, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the biopharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and setting ambitious targets to mitigate climate impact. Reliable Biopharmaceutical may benefit from aligning with industry standards and frameworks, such as the Science Based Targets initiative (SBTi), to establish measurable goals for reducing emissions across all scopes. As the industry moves towards greater transparency and accountability in climate action, it will be crucial for Reliable Biopharmaceutical to develop and communicate its strategies for reducing its carbon footprint in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Reliable Biopharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
